6-51830843-T-C
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_138694.4(PKHD1):c.8302+18A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0507 in 1,609,690 control chromosomes in the GnomAD database, including 2,357 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.053 ( 224 hom., cov: 32)
Exomes 𝑓: 0.050 ( 2133 hom. )
Consequence
PKHD1
NM_138694.4 intron
NM_138694.4 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.627
Genes affected
PKHD1 (HGNC:9016): (PKHD1 ciliary IPT domain containing fibrocystin/polyductin) The protein encoded by this gene is predicted to have a single transmembrane (TM)-spanning domain and multiple copies of an immunoglobulin-like plexin-transcription-factor domain. Alternative splicing results in two transcript variants encoding different isoforms. Other alternatively spliced transcripts have been described, but the full length sequences have not been determined. Several of these transcripts are predicted to encode truncated products which lack the TM and may be secreted. Mutations in this gene cause autosomal recessive polycystic kidney disease, also known as polycystic kidney and hepatic disease-1. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.92).
BP6
Variant 6-51830843-T-C is Benign according to our data. Variant chr6-51830843-T-C is described in ClinVar as [Benign]. Clinvar id is 96430.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.0663 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0529 AC: 8051AN: 152098Hom.: 223 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
8051
AN:
152098
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.0522 AC: 13110AN: 251020 AF XY: 0.0527 show subpopulations
GnomAD2 exomes
AF:
AC:
13110
AN:
251020
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0505 AC: 73588AN: 1457474Hom.: 2133 Cov.: 28 AF XY: 0.0513 AC XY: 37231AN XY: 725268 show subpopulations
GnomAD4 exome
AF:
AC:
73588
AN:
1457474
Hom.:
Cov.:
28
AF XY:
AC XY:
37231
AN XY:
725268
Gnomad4 AFR exome
AF:
AC:
2002
AN:
33320
Gnomad4 AMR exome
AF:
AC:
1793
AN:
44628
Gnomad4 ASJ exome
AF:
AC:
990
AN:
26042
Gnomad4 EAS exome
AF:
AC:
3312
AN:
39614
Gnomad4 SAS exome
AF:
AC:
6316
AN:
86182
Gnomad4 FIN exome
AF:
AC:
3033
AN:
53368
Gnomad4 NFE exome
AF:
AC:
53043
AN:
1108396
Gnomad4 Remaining exome
AF:
AC:
2916
AN:
60174
Heterozygous variant carriers
0
3377
6754
10131
13508
16885
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Exome Het
Exome Hom
Variant carriers
0
1924
3848
5772
7696
9620
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0530 AC: 8070AN: 152216Hom.: 224 Cov.: 32 AF XY: 0.0530 AC XY: 3943AN XY: 74414 show subpopulations
GnomAD4 genome
AF:
AC:
8070
AN:
152216
Hom.:
Cov.:
32
AF XY:
AC XY:
3943
AN XY:
74414
Gnomad4 AFR
AF:
AC:
0.0601954
AN:
0.0601954
Gnomad4 AMR
AF:
AC:
0.0363267
AN:
0.0363267
Gnomad4 ASJ
AF:
AC:
0.0348703
AN:
0.0348703
Gnomad4 EAS
AF:
AC:
0.0526824
AN:
0.0526824
Gnomad4 SAS
AF:
AC:
0.0725539
AN:
0.0725539
Gnomad4 FIN
AF:
AC:
0.0565824
AN:
0.0565824
Gnomad4 NFE
AF:
AC:
0.0522871
AN:
0.0522871
Gnomad4 OTH
AF:
AC:
0.0458846
AN:
0.0458846
Heterozygous variant carriers
0
389
778
1168
1557
1946
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Genome Hom
Variant carriers
0
100
200
300
400
500
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
332
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:2
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Feb 04, 2016
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Autosomal recessive polycystic kidney disease Benign:2
Jan 29, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Apr 13, 2018
Natera, Inc.
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
- -
not provided Benign:1
Jul 09, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
Mutation Taster
=100/0
polymorphism (auto)
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at